A clinical trial investigating the effectiveness of a new tooth- and bone-borne rapid expansion device in patients with jaw deformities with severe maxillary transverse deficiency

Kamioka Hiroshi0 sites10 target enrollmentFebruary 16, 2022

Overview

No summary available.

Registry

who.int

Start Date

February 16, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Kamioka Hiroshi

•1\) patients with jaw deformities with severe maxillary transverse deficiency between the ages of 15 and 29
•2\) Person who obtained document consent by the patient's or legal representative's free will

•1\) Patients who cannot obtain cooperation for treatment
•2\) Patients who have extremely poor oral hygiene
•3\) Patients with unmanageable severe systemic disease, bleeding disease, endocrine disease
•4\) Patients with or have a history of drug, alcohol, or nicotine addiction
•5\) Patients with diseases that require regular steroid administration
•6\) Patients receiving bisphosphonates
•7\) Patients with xerostomia, opportunistic immunodeficiency or leukocyte dysfunction
•8\) Patients with hypersensitivity to pure titanium / titanium alloy, Nikel
•9\) Patients with lesions such as inflammation and tumor in the area around the screw planting
•10\) In addition, patients who are judged by the principal investigator and the investigator to be inappropriate as research subjects